Skip to main content
OpenTrials

Clinical trial condition

Generalized Myasthenia Gravis

Explore clinical trials studying Generalized Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

51 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Generalized Myasthenia Gravis trial results

Recruiting

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

NCT07294170

Conditions
AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
Locations
  • Profound Research LLC - Carlsbad Carlsbad, California, United States
  • Visionary Investigators Network Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Erlanger Health System Columbia, Maryland, United States
View all 29 locations
View Trial Details
Recruiting

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

NCT07284420

Conditions
AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
Locations
  • Profound Research LLC - Carlsbad Carlsbad, California, United States
  • Visionary Investigators Network Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Henry Ford Health Systems Detroit, Michigan, United States
View all 24 locations
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

NCT07039916

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Site Number - 1056 Huntsville, Alabama, United States
  • Site Number - 1041 Mobile, Alabama, United States
  • Site Number - 1017 Phoenix, Arizona, United States
  • Site Number - 1025 Scottsdale, Arizona, United States
View all 88 locations
View Trial Details
Recruiting

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

NCT06463587

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Arizona Neuroscience Research, LLC Phoenix, Arizona, United States
  • Advanced Neurosciences Research LLC Longmont, Colorado, United States
  • University of Connecticut Health Center - Department of Medicine Farmington, Connecticut, United States
  • The George Washington University Medical Faculty Associates Foggy Bottom South Pavilion Washington D.C., District of Columbia, United States
View all 145 locations
View Trial Details
Recruiting

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

NCT06987539

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Austin Neuromuscular Center Austin, Texas, United States
  • Hopital Armand Trousseau Paris, France
  • Hospital Universitari i Politecnic La Fe Valencia, Spain
  • John Radcliffe Hospital Headington, Oxford, United Kingdom
View Trial Details
Recruiting

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

NCT06193889

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • University of California, Irvine Orange, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 22 locations
View Trial Details
Recruiting

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

NCT06704269

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
  • Wake Forest Univ School of Medicine Winston-Salem, North Carolina, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Houston Methodist Hospital Houston, Texas, United States
View Trial Details
Recruiting

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

NCT06517758

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Fullerton Neuro and Headache Ctr Fullerton, California, United States
  • SC3 Research Pasadena Pasadena, California, United States
  • California Pacific Medical Center Sacramento, California, United States
View all 125 locations
View Trial Details
Recruiting

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

NCT06456580

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • HonorHealth Neurology - Bob Bové Neuroscience Institute Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 111 locations
View Trial Details

Related conditions